![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Abiomed’s Heart Pump
FDA Approves Abiomed’s Heart Pump
Danvers, Mass.-based Abiomed’s right-heart pump, the Impella RP with SmartAssist, has received premarket approval from the FDA.
In June 2020, the FDA issued an Emergency Use Authorization for the Impella RP as a treatment for patients suffering from COVID-19-related right-heart failure or decompensation, including pulmonary embolism.
The pump, which is now cleared to treat acute right-heart failure for up to 14 days, includes sensors that allow remote monitoring from internet-connected devices.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct